Upregulation of PD-L1 expression in tumor cells is triggered by activation of the cGAS/STING pathway, followed by IFNα/β, or IFN-γ by CD8+ T cells, or the IL-6-mediated STAT-IRF1 pathway [50,51,52,53]. Here, IFNG is linked to neoplasm.